No photo available yet
Agilent Technologies Sialic Acid Profiling and Quantitation Kits | Analysis
Agilent Technologies Sialic Acid Profiling and Quantitation Kits | Analysis — Biopharma hplc analysis with Pumping speed 2.4×10⁻⁵ m³/h.
The AdvanceBio Sialic Acid Profiling and Quantitation workflow (kit GKK-407) is a 96-well-plate sample-prep and 10-minute RP-UHPLC/FLD method for sialic acid release, DMB labeling and quantitation in biotherapeutic glycoproteins. It runs on a 1290 Infinity II LC with Infinity multisampler and a 120 column, detected by FLD or optional 6545 LC/Q-TOF MS. It is the sialic-acid-specific member of the AdvanceBio glycan workflow family, distinct from amino-acid, Gly-X, HIC and EC-C18 siblings.
Agilent Technologies Glycan Preparation Series — Model Comparison & Selection
| Model | Mass range | Nozzle voltage, V | Sheath gas flow, liter/minute | Fluorescence detector maximum data rate, Hz | Glycan sample preparation time, h | Pumping speed, m³/h |
|---|---|---|---|---|---|---|
| Sialic Acid Profiling and Quantitation Kits | Analysis Current | — | 1800 | 12 | 74 | 1 | 2.4×10⁻⁵ |
| AdvanceBio Gly-X Technology | N-glycan Analysis | 600...3,000 | 500 | 10 | 74 | 1 | — |
Full specifications
| Pumping speed | 0.4 mL/min |
| Fluorescence Detector Maximum Data Rate | 74 Hz |
| Glycan Sample Preparation Time | 1 hour |
| Ion source | Dual AJS ESI |
| Run Time | 10 min |
| Sample volume | 20 µL |
| Sheath Gas Flow | 12 L/min |
| Software | 2.3 |
| LC system mfr | 1290 System |
| Autosampler mfr | Agilent Infinity multisampler multisampler |
| Column mfr | 120 |
| Detection mfr | FLD or MS MS |
| Kit order number mfr | -407 |
| Mass spectrometer mfr | 6545 TOF |
| Fragmentor Voltage | 120 V |
| Nozzle Voltage | 1800 V |
| Mobile phase A mfr | 100 |
| Mobile phase B mfr | acetonitrile acetonitrile |
| Gas Temperature | 350 °C |
| Sheath Gas Temperature | 400 °C |
| Sialic acid release mfr | 2 °C |
| DMB labeling mfr | 3 °C |
Description
Construction and positioning in the series
- This is a kit-based analytical workflow, not a standalone instrument: the deliverable is the GKK-407 sialic acid profiling/quantitation kit plus the validated 10-minute RP-UHPLC/FLD method, executed on a 1290 Infinity II LC system with Agilent Infinity multisampler and a 120 column.
- Within the AdvanceBio siblings it is the only sialic-acid-specific workflow; the amino-acid analysis (AAA), Gly-X, HIC and EC-C18 entries address different glycan/protein separations and are not interchangeable with this kit.
- Sample preparation is a 1-hour, 96-well-plate procedure comprising sialic acid release and DMB labeling steps before injection.
Behavior in the analytical run
- The separation is a 10-minute reversed-phase UHPLC run at 0.4 mL/min with a 20 µL injection; mobile phase A is 100 (aqueous) and mobile phase B is acetonitrile.
- Detection is fluorescence (FLD) as the standard path, with mass spectrometry as an optional confirmatory path on the 6545 LC/Q-TOF using a Dual AJS ESI source: fragmentor 120 V, nozzle 1800 V, gas temperature 350 °C, sheath gas 12 L/min at 400 °C.
- The FLD data rate is 74 Hz; the workflow has been demonstrated on rituximab, etanercept, NISTmAb and cetuximab per the application note.
Control, software and operation
- Method control and quantitation run under software version 2.3; the leaflet names MassHunter BioConfirm and the Glycan Peak Assignment Tool as the data-processing environment for the broader glycan workflow.
- The application note defines the kit as usable in 96-well plate format, so plate-handling capacity of the multisampler and the plate-based prep bench are the practical throughput limits.
- No certificates, environmental ratings or curve data are supplied for this workflow; performance claims rest on the application note and leaflet only.
Integration & Operating Notes
The 96-well sample preparation is a 1-hour procedure split into a sialic acid release stage and a DMB labeling stage; the 10-minute LC run time is only the analytical part, so plate throughput planning must budget the full prep hour before the first injection and for each subsequent plate.
Selection & Integration Q&A
Pick this kit (GKK-407) when the analyte is sialic acid released from a glycoprotein and quantitated by DMB labeling with a 10-minute RP-UHPLC/FLD run. The AAA sibling targets amino acids, Gly-X targets N-glycan labeling (InstantPC/2-AB), and HIC/EC-C18 are separation chemistries, so none substitutes for sialic acid release and labeling.
Preparation is a 1-hour, 96-well-plate procedure covering sialic acid release and DMB labeling, separate from the 10-minute analytical run. Plate throughput is therefore set by the prep hour plus the multisampler's plate capacity, and the workflow has been demonstrated on rituximab, etanercept, NISTmAb and cetuximab.
The base item is the AdvanceBio Sialic Acid profiling and quantitation kit, order number GKK-407. The 120 column, mobile phase A and acetonitrile B, the 1290 LC with Infinity multisampler, the FLD or 6545 LC/Q-TOF, and software 2.3 are separate; no certificates or accessory cables are listed for this workflow, so consumable and column replacement must be planned independently.